CNN logo

Infoseek/Big Yellow

Pathfinder/Warner Bros

Barnes and Noble

Health banner

Diet drug risks may have been known years ago

Redux December 11, 1997
Web posted at: 8:06 p.m. EST (0106 GMT)

(CNN) -- Questions are being raised about whether drug companies and federal regulators knew that two popular diet drugs were linked to heart damage years before they were pulled from the U.S. market.

In September, the U.S. Food and Drug Administration called for the withdrawal of the two drugs -- Redux, known generically as dexfenfluramine, and fenfluramine, the "fen" in the diet drug combination "fen-phen" -- after reports of an unusual heart valve disease.

In a letter to the New England Journal of Medicine, Belgian officials said they received similar reports dating back to 1994. Thirty-one women in that country with heart valve problems had been taking diet drugs, including fen-phen, the letter said.

In a statement released Thursday, the FDA acknowledged it had heard about some of the side effects with the diet pills before it approved Redux, the newer of the two drugs.

"However, these scattered reports were not easily linked to one another because they did not specify heart valvular disease as the primary adverse event and were identified more generally as heart, kidney or lung disorders," the FDA statement said.

Wyeth-Ayerst, manufacturer of the two drugs in the United States, said in a statement that it had informed the FDA of the reactions, as required.

But the drug company and the FDA both said the Belgian reports were complicated by the fact that many of the women were also using Chinese herbs to lose weight.

In its statement, Wyeth-Ayerst said that while some of the cases included heart valve problems, the patients' conditions "were ascribed to their use of Chinese herbs." The company also said that "to our knowledge, the Belgian authorities took no action regarding either (drug) based on the reports."

"Wyeth-Ayerst does not believe these cases, even with the benefit of hindsight, demonstrate that heart valve problems are caused by either of these drugs," the statement said.

The FDA continues to evaluate matters relating to the two drugs and their effects on public health, and Wyeth-Ayerst has set up a panel to investigate the matter.

CNN Plus

Related stories:

Related sites:

Note: Pages will open in a new browser window

External sites are not endorsed by CNN Interactive.

Infoseek search  

Message Boards Sound off on our
message boards

You said it...
To the top

© 1997 Cable News Network, Inc.
All Rights Reserved.

Terms under which this service is provided to you.